Patents by Inventor Philip Wahl

Philip Wahl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12237651
    Abstract: A device for the ionization of gaseous media, comprising a feed channel (101) having a gas feed, a distribution channel (104) having at least one gas outlet, and at least one ionization unit (304), wherein the at least one ionization unit (304) is designed as a connecting channel from the feed channel (101) to the distribution channel (104) and is provided with an electrode (102) and an associated counter electrode (106). The electrode (102) is configured to ionize gas flowing through the ionization unit (304) from the feed channel (101) to the distribution channel (104), wherein the gas flows around the electrode (102), and the at least one gas outlet is designed in the form of one or more nozzles (107) or a plurality of openings (107).
    Type: Grant
    Filed: June 1, 2022
    Date of Patent: February 25, 2025
    Assignee: Kist + Eschrich GmbH
    Inventors: Reiner Wahl, Stefan Kist, Thomas Eckardt, Scott Trimble, Alec Smith, Philip Anthony
  • Publication number: 20130303946
    Abstract: A wearable article for detecting an impact to the head is provided. The wearable article includes a first flexible layer and a second flexible layer. A sensor is disposed between the first flexible layer and the second flexible layer. An indicator device is operably coupled to the sensor, the indicator device being configured to to provide a visual indication of the level of the impact.
    Type: Application
    Filed: May 7, 2013
    Publication date: November 14, 2013
    Applicant: WESTERN NEW ENGLAND UNIVERSITY
    Inventors: Robert T. T. Gettens, Nathan Kuzmeski, Lindsay Tencza, Nicholas St. John, Thomas McLeod, Philip Wahl, James C. McKeon, Glenn E. Vallee
  • Publication number: 20080026987
    Abstract: The present invention provides a method of normalizing blood glucose levels in mammals utilizing liver-selective glucokinase activators. The present invention also provides a method of increasing liver metabolism and decreasing apoptosis independent of glucose normalization or hyperglycemic conditions.
    Type: Application
    Filed: June 17, 2005
    Publication date: January 31, 2008
    Applicant: Novo Nordisk A/S
    Inventors: Peter Mackay, James Mackay, Carmen Valcarce-Lopez, Thora Bodvarsdottir, Keld Fosgerau, Marianne Larsen, Per Arkhammar, Philip Wahl
  • Publication number: 20060035314
    Abstract: Proteins capable of binding meiosis activating sterols (MAS), designated SAM1a and SAM1b, and useful in methods for assaying MAS receptor ligands, agonists and antagonists, as well as DNA sequences encoding such proteins.
    Type: Application
    Filed: August 22, 2001
    Publication date: February 16, 2006
    Inventors: Philip Wahl, Henrik Vissing, Christian Grondahl
  • Publication number: 20030219791
    Abstract: Two receptors of meiosis activating sterols designated SAM1a and SAM1b have been identified.
    Type: Application
    Filed: February 20, 2003
    Publication date: November 27, 2003
    Inventors: Vibeke Westphal Stennicke, Peder Lisby Norby, Christian Grondahl, Philip Wahl